Bioasis Technologies (TSXV:BTI) Short-Term Debt : C$1.50 Mil (As of Nov. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Bioasis Technologies Short-Term Debt?

Bioasis Technologies's Short-Term Debt for the quarter that ended in Nov. 2022 was C$1.50 Mil.

Bioasis Technologies's quarterly Short-Term Debt stayed the same from May. 2022 (C$1.50 Mil) to Aug. 2022 (C$1.50 Mil) and stayed the same from Aug. 2022 (C$1.50 Mil) to Nov. 2022 (C$1.50 Mil).

Bioasis Technologies's annual Short-Term Debt declined from Feb. 2020 (C$0.49 Mil) to Feb. 2021 (C$0.06 Mil) but then increased from Feb. 2021 (C$0.06 Mil) to Feb. 2022 (C$1.50 Mil).

Bioasis Technologies Short-Term Debt Historical Data

The historical data trend for Bioasis Technologies's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies Short-Term Debt Chart

Bioasis Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Short-Term Debt

Get a 7-Day Free Trial

0.49

0.06

1.50

Bioasis Technologies Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Short-Term Debt	Get a 7-Day Free Trial															1.50	1.50	1.50	1.50	1.50

Bioasis Technologies Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Bioasis Technologies Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioasis Technologies (TSXV:BTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (TSXV:BTI) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

157 Church Street, 19th Floor, New Haven, CT, USA, 06510

Website

https://www.bioasis.us

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.